HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative ...
Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, ...
Explore the US Justice Department's reclassification of medical cannabis to Schedule III, impacting tax breaks for businesses ...
A Travis County district judge has extended a temporary injunction, allowing Texas shops to continue selling smokable hemp ...
The US Justice Department's recent order reclassifies medical cannabis, removing it from Schedule I. This move impacts ...
Indiana Governor Mike Braun signals a shift in medical cannabis policy after federal rescheduling. A RAND study details ...
The DEA has launched an online registration portal for state-licensed medical cannabis firms, providing federal recognition, ...
Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and ...
Trulieve Cannabis Corp. has filed applications for DEA registration of its state-licensed medical marijuana businesses, ...
A recent cannabidiol gel trial for Fragile X Syndrome did not meet its primary endpoint, largely due to a high placebo ...
A new poll reveals 75% of Texas voters support medical cannabis reforms, despite low awareness of the state's Compassionate ...
Explore how Curaleaf's full acquisition of EU-GMP licensed Four 20 Pharma solidifies its presence in the expanding German ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results